We’ve recently updated our valuation analysis.

Kronos Worldwide Valuation

Is KRO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

[object Object] Score

3/6

Valuation Score 3/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for KRO?

Other financial metrics that can be useful for relative valuation.

KRO key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.5x
Enterprise Value/EBITDA4.5x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does KRO's PE Ratio compare to its peers?

The above table shows the PE ratio for KRO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average14x
OEC Orion Engineered Carbons
11.9x22.7%US$1.1b
ASIX AdvanSix
7x-0.1%US$1.1b
MATV Mativ Holdings
26.3x112.1%US$1.1b
WLKP Westlake Chemical Partners
10.6x0.01%US$817.1m
KRO Kronos Worldwide
6.8xn/aUS$1.1b

Price-To-Earnings vs Peers: KRO is good value based on its Price-To-Earnings Ratio (6.8x) compared to the peer average (14x).


Price to Earnings Ratio vs Industry

How does KRO's PE Ratio compare vs other companies in the US Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a10.3%
n/an/an/a

Price-To-Earnings vs Industry: KRO is good value based on its Price-To-Earnings Ratio (6.8x) compared to the US Chemicals industry average (15x)


Price to Earnings Ratio vs Fair Ratio

What is KRO's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

KRO PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio6.8x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate KRO's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of KRO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: KRO ($9.15) is trading below our estimate of fair value ($9.22)

Significantly Below Fair Value: KRO is trading below fair value, but not by a significant amount.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst KRO forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$9.15
US$10.00
+9.3%
16.3%US$12.00US$8.00n/a3
Nov ’23US$9.60
US$9.67
+0.7%
17.6%US$12.00US$8.00n/a3
Oct ’23US$9.34
US$13.00
+39.2%
38.5%US$18.00US$8.00n/a2
Sep ’23US$13.03
US$16.50
+26.6%
9.1%US$18.00US$15.00n/a2
Aug ’23US$17.74
US$18.00
+1.5%
11.1%US$20.00US$16.00n/a2
Jul ’23US$18.22
US$18.00
-1.2%
11.1%US$20.00US$16.00n/a2
Jun ’23US$19.60
US$18.00
-8.2%
11.1%US$20.00US$16.00n/a2
May ’23US$15.22
US$17.00
+11.7%
5.9%US$18.00US$16.00n/a2
Apr ’23US$15.77
US$17.00
+7.8%
5.9%US$18.00US$16.00n/a2
Mar ’23US$14.35
US$16.00
+11.5%
0%US$16.00US$16.00n/a2
Feb ’23US$14.53
US$16.00
+10.1%
0%US$16.00US$16.00n/a2
Jan ’23US$15.01
US$16.00
+6.6%
0%US$16.00US$16.00n/a2
Dec ’22US$13.91
US$16.00
+15.0%
0%US$16.00US$16.00US$9.152
Nov ’22US$13.31
US$15.50
+16.5%
3.2%US$16.00US$15.00US$9.602
Oct ’22US$12.71
US$15.50
+22.0%
3.2%US$16.00US$15.00US$9.342
Sep ’22US$12.90
US$15.50
+20.2%
3.2%US$16.00US$15.00US$13.032
Aug ’22US$13.91
US$17.50
+25.8%
8.6%US$19.00US$16.00US$17.742
Jul ’22US$14.27
US$17.50
+22.6%
8.6%US$19.00US$16.00US$18.222
Jun ’22US$16.76
US$17.50
+4.4%
8.6%US$19.00US$16.00US$19.602
May ’22US$17.00
US$17.75
+4.4%
1.4%US$18.00US$17.50US$15.222
Apr ’22US$15.44
US$14.75
-4.5%
18.6%US$17.50US$12.00US$15.772
Mar ’22US$14.93
US$14.00
-6.2%
14.3%US$16.00US$12.00US$14.352
Feb ’22US$14.54
US$14.00
-3.7%
14.3%US$16.00US$12.00US$14.532
Jan ’22US$14.91
US$14.00
-6.1%
14.3%US$16.00US$12.00US$15.012
Dec ’21US$13.94
US$14.00
+0.4%
14.3%US$16.00US$12.00US$13.912

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies